RenaissanceRe Holdings Ltd. Stock

Equities

RNR

BMG7496G1033

Reinsurance

Market Closed - Nyse 04:00:02 2024-05-10 pm EDT 5-day change 1st Jan Change
225.8 USD -0.03% Intraday chart for RenaissanceRe Holdings Ltd. +3.40% +15.18%
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last Days!
Take advantage of the offer
* See conditions on site
Sales 2024 * 10.62B Sales 2025 * 11.6B Capitalization 11.94B
Net income 2024 * 1.53B Net income 2025 * 1.69B EV / Sales 2024 * 1.12 x
Net cash position 2024 * - Net cash position 2025 * - EV / Sales 2025 * 1.03 x
P/E ratio 2024 *
7.82 x
P/E ratio 2025 *
6.69 x
Employees 925
Yield 2024 *
0.69%
Yield 2025 *
0.72%
Free-Float 98.11%
More Fundamentals * Assessed data
Dynamic Chart
UBS Raises RenaissanceRe Holdings Price Target to $251 From $241, Maintains Neutral Rating MT
Transcript : RenaissanceRe Holdings Ltd., Q1 2024 Earnings Call, May 01, 2024
RenaissanceRe Holdings Q1 Operating Earnings, Net Premiums Rise MT
Earnings Flash (RNR) RENAISSANCERE HOLDINGS Reports Q1 EPS $12.18, vs. Street Est of $9.34 MT
Earnings Flash (RNR) RENAISSANCERE HOLDINGS Reports Q1 Revenue $2.6B, vs. Street Est of $3.19B MT
RenaissanceRe Holdings Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Evercore ISI Adjusts Price Target on RenaissanceRe Holdings to $216 From $213, Maintains Underperform Rating MT
Renaissancere Holdings Insider Sold Shares Worth $586,411, According to a Recent SEC Filing MT
RenaissanceRe Raises Dividend to $0.39 per Share From $0.38, Payable March 29 to Holders of Record on March 15 MT
RenaissanceRe Holdings Ltd. Increases Its Quarterly Dividend, Payable on March 29, 2024 CI
UBS Adjusts RenaissanceRe Price Target to $238 From $229, Maintains Neutral Rating MT
BMO Capital Adjusts Price Target on RenaissanceRe Holdings to $295 From $216, Maintains Outperform Rating MT
Transcript : RenaissanceRe Holdings Ltd., Q4 2023 Earnings Call, Jan 31, 2024
RenaissanceRe's Q4 Operating Earnings, Revenue Increase MT
Earnings Flash (RNR) RENAISSANCERE HOLDINGS Posts Q4 Revenue $3.24B, vs. Street Est of $1.72B MT
More news
1 day-0.03%
1 week+3.40%
Current month+2.96%
1 month+1.52%
3 months-0.08%
6 months+7.54%
Current year+15.18%
More quotes
1 week
218.50
Extreme 218.5
229.48
1 month
212.18
Extreme 212.18
234.58
Current year
196.95
Extreme 196.95
239.42
1 year
174.22
Extreme 174.22
239.42
3 years
124.18
Extreme 124.18
239.42
5 years
113.27
Extreme 113.27
239.42
10 years
93.89
Extreme 93.8901
239.42
More quotes
Managers TitleAgeSince
Chief Executive Officer 57 95-12-31
Director of Finance/CFO 62 16-08-07
Chief Tech/Sci/R&D Officer - 09-12-31
Members of the board TitleAgeSince
Director/Board Member 60 22-05-15
Director/Board Member 69 08-04-30
Chief Executive Officer 57 95-12-31
More insiders
Date Price Change Volume
24-05-10 225.8 -0.03% 191,861
24-05-09 225.8 -0.35% 144,453
24-05-08 226.6 +0.64% 235,397
24-05-07 225.2 +0.99% 412,589
24-05-06 223 +2.13% 268,889

Delayed Quote Nyse, May 10, 2024 at 04:00 pm EDT

More quotes
RenaissanceRe Holdings Ltd. is a global provider of reinsurance and insurance. The Company provides property, casualty and specialty reinsurance and certain insurance solutions to customers, principally through intermediaries. The Company has two segments. The Property segment is comprised of catastrophe and other property reinsurance and insurance written on behalf of its operating subsidiaries, joint ventures, and managed funds. The Casualty and Specialty segment is comprised of casualty and specialty reinsurance and insurance written on behalf of its operating subsidiaries, joint ventures, and managed funds. The Company writes catastrophe reinsurance and insurance coverage protecting against natural and man-made catastrophes, such as earthquakes, hurricanes, typhoons and tsunamis, winter storms, freezes, floods, fires, windstorms, tornadoes, explosions and acts of terrorism, among others. Its subsidiaries include Renaissance Reinsurance Ltd., Validus Reinsurance Ltd. and others.
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
C
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
12
Last Close Price
225.8 USD
Average target price
266.8 USD
Spread / Average Target
+18.19%
Consensus
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW